(MedPage Today) — The dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro, Zepbound) was just as cardioprotective as the GLP-1 drug dulaglutide (Trulicity) in patients with type 2 diabetes and atherosclerotic cardiovascular disease, a large…
Multi-sports facility Pretty Huge launches Hyrox training area
The Hyrox Training Area is equipped with a full Hyrox simulation setup. Source: www.philstar.com Medical Disclaimer: This content is shared...






